|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
29,730,000 |
Market
Cap: |
1.43(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$26.52 - $75.32 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 20 |
Insider 3/6 Months : 20.6 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Gemeni Therapeutics is a clinical-stage precision medicine company developing therapeutic compounds to treat genetically defined, age-related macular degeneration (AMD). Co.'s lead product candidate, GEM103, is a recombinant form of the human complement factor H protein and is designed to address complement hyperactivity and overall dysregulation caused by loss of function mutations thus restoring retinal health in patients with AMD.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
388,891 |
388,891 |
1,041,066 |
Total Buy Value |
$0 |
$14,000,076 |
$14,000,076 |
$29,000,101 |
Total People Bought |
0 |
3 |
3 |
4 |
Total Buy Transactions |
0 |
3 |
3 |
6 |
Total Shares Sold |
5,359 |
10,077 |
1,816,761 |
3,929,683 |
Total Sell Value |
$262,142 |
$419,912 |
$108,633,360 |
$210,494,186 |
Total People Sold |
2 |
2 |
9 |
13 |
Total Sell Transactions |
5 |
8 |
40 |
59 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Leonard Braden Michael |
10% Owner |
|
2022-04-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,000,000 |
|
- |
|
Leonard Braden Michael |
10% Owner |
|
2022-04-11 |
4 |
B |
$1.35 |
$681,057 |
I/I |
504,487 |
4,604,487 |
1.5 |
- |
|
Meyenburg Jason Patrick |
President & CEO |
|
2021-05-14 |
4 |
B |
$9.46 |
$122,929 |
D/D |
13,000 |
13,000 |
2.81 |
- |
|
Piekos Brian |
Chief Financial Officer |
|
2021-05-14 |
4 |
B |
$9.46 |
$72,432 |
D/D |
7,655 |
7,655 |
2.74 |
- |
|
George Jean |
Director |
|
2021-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,836,106 |
|
- |
|
Plain Henry A Jr |
10% Owner |
|
2021-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,836,106 |
|
- |
|
Atlas Venture Associates Xii, Llc |
10% Owner |
|
2021-02-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,254,365 |
|
- |
|
Rhodes Jason P |
Director |
|
2021-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,254,365 |
|
- |
|
Orbimed Capital Gp Vi Llc |
Director |
|
2021-02-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,826,224 |
|
- |
|
Lauder Scott |
Chief Technology OfficerOffice |
|
2021-02-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
104,622 |
|
- |
|
Gordon Carl L |
Director |
|
2021-02-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,826,224 |
|
- |
|
Tananbaum James B. |
Director |
|
2021-02-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,928,750 |
2,928,750 |
|
- |
|
Tananbaum James B. |
Director |
|
2021-02-05 |
4 |
A |
$10.00 |
$15,000,000 |
I/I |
1,500,000 |
1,500,000 |
|
- |
|
Foresite Capital Opportunity Management V, Llc |
Director by Deputization |
|
2021-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,928,750 |
2,928,750 |
|
- |
|
Foresite Capital Opportunity Management V, Llc |
Director by Deputization |
|
2021-02-05 |
4 |
A |
$10.00 |
$15,000,000 |
D/D |
1,500,000 |
1,500,000 |
|
- |
|
Foresite Capital Opportunity Management V, Llc |
10% Owner |
|
2020-10-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
441,500 |
|
- |
|
Tananbaum James B. |
President & CEO |
|
2020-08-14 |
4 |
B |
$10.00 |
$4,415,000 |
D/D |
441,500 |
441,500 |
3.23 |
- |
|
117 Records found
|
|
Page 5 of 5 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|